TY - JOUR
T1 - Gestational Diabetes—Screening, Prevalence and Postpartum Diabetes
T2 - Population-Based Cohort Study
AU - Lutski, Miri
AU - Saban, Mor
AU - Novick, Debbie
AU - Tirosh, Amir
AU - Raz, Itamar
AU - Tsur, Anat
AU - Zucker, Inbar
N1 - Publisher Copyright:
© 2025 The Author(s). Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.
PY - 2025/7/1
Y1 - 2025/7/1
N2 - Aims: To evaluate GDM screening compliance and prevalence, and the association between gestational glucose intolerance and 5-year postpartum diabetes mellitus (DM). Materials and Methods: We used population-based data from three Israeli health maintenance organisations (HMOs), covering 75% of all births in 2016. GDM screening followed a two-step approach: a 50-g 1-h oral glucose challenge test (OGCT), followed by a 100-g 3-h oral glucose tolerance test (OGTT) using Carpenter-Coustan criteria. Data included age, socioeconomic status (SES), results of OGCT and OGTT tests, child birth weight, and gestational age. The dataset was linked to the Israeli National Diabetes Registry to identify postpartum DM. Logistic regression models estimated odds ratios (ORs) for GDM and postpartum DM, adjusting for maternal age, SES, ethnicity, and glucose tolerance status. Results: Among 128,454 women, 10% were unscreened. Of those screened, 23,451 underwent the full OGTT. GDM prevalence was 4.3%. Postpartum DM incidence was 8.6% in women with GDM, 3.1% with unknown GDM status, and 2.1% with impaired glucose tolerance (IGT) (defined as one abnormal value on the OGTT). Compared with normoglycemia, adjusted ORs for the 5-year postpartum DM were 25.48 (95% CI: 21.80–29.79) for GDM, 10.04 (95% CI: 8.59–11.74) for unknown GDM status, 6.48 (95% CI: 5.07–8.28) for IGT, and 2.17 (95% CI: 1.63–2.88) for abnormal OGCT with normal OGTT. Older age, lower SES, and Arab or Bedouin ethnicity were linked to higher GDM and postpartum DM. Conclusions: Gestational glucose intolerance and screening gaps were strong predictors of postpartum DM. Age, SES, and ethnicity highlight the need for targeted efforts to reduce health disparities.
AB - Aims: To evaluate GDM screening compliance and prevalence, and the association between gestational glucose intolerance and 5-year postpartum diabetes mellitus (DM). Materials and Methods: We used population-based data from three Israeli health maintenance organisations (HMOs), covering 75% of all births in 2016. GDM screening followed a two-step approach: a 50-g 1-h oral glucose challenge test (OGCT), followed by a 100-g 3-h oral glucose tolerance test (OGTT) using Carpenter-Coustan criteria. Data included age, socioeconomic status (SES), results of OGCT and OGTT tests, child birth weight, and gestational age. The dataset was linked to the Israeli National Diabetes Registry to identify postpartum DM. Logistic regression models estimated odds ratios (ORs) for GDM and postpartum DM, adjusting for maternal age, SES, ethnicity, and glucose tolerance status. Results: Among 128,454 women, 10% were unscreened. Of those screened, 23,451 underwent the full OGTT. GDM prevalence was 4.3%. Postpartum DM incidence was 8.6% in women with GDM, 3.1% with unknown GDM status, and 2.1% with impaired glucose tolerance (IGT) (defined as one abnormal value on the OGTT). Compared with normoglycemia, adjusted ORs for the 5-year postpartum DM were 25.48 (95% CI: 21.80–29.79) for GDM, 10.04 (95% CI: 8.59–11.74) for unknown GDM status, 6.48 (95% CI: 5.07–8.28) for IGT, and 2.17 (95% CI: 1.63–2.88) for abnormal OGCT with normal OGTT. Older age, lower SES, and Arab or Bedouin ethnicity were linked to higher GDM and postpartum DM. Conclusions: Gestational glucose intolerance and screening gaps were strong predictors of postpartum DM. Age, SES, and ethnicity highlight the need for targeted efforts to reduce health disparities.
KW - cohort study
KW - gestational diabetes
KW - incidence
KW - postpartum diabetes
KW - registry
KW - screening
UR - https://www.scopus.com/pages/publications/105010845211
U2 - 10.1002/dmrr.70068
DO - 10.1002/dmrr.70068
M3 - Article
C2 - 40673650
AN - SCOPUS:105010845211
SN - 1520-7552
VL - 41
JO - Diabetes/Metabolism Research and Reviews
JF - Diabetes/Metabolism Research and Reviews
IS - 5
M1 - e70068
ER -